Colorful flags fluttered in the wind, and machinery stood ready for a new chapter.

On the morning of August 18, 2026, the groundbreaking and foundation-laying ceremony for the Phase I construction project of Jiangsu Yiling Pharmaceutical Development Co., Ltd. was grandly held at the project site in Jinhu Economic Development Zone, Huai'an. The successful commencement marked the official entry of the Jiangsu Yiling project into the full construction phase, and also represented a critical strategic move by Beijing Pharmatech Science & Technology Development Co., Ltd. to deepen its presence in the Yangtze River Delta and complete its full-industry-chain layout.

The ceremony drew a distinguished gathering of government officials, corporate leaders, and partners, who came together to witness this milestone moment for the project. Mr. Huang Yuhua, Director of the Administrative Committee of Jiangsu Jinhu Economic Development Zone, attended the event. Mr. Guan Yi, Chairman of Beijing Pharmatech Science & Technology Development Co., Ltd., led the group's management team to the site. Mr. Xu Jun, General Manager of the project's construction contractor, Jinhu County Hucheng Construction Co., Ltd., was also invited to the scene, jointly empowering the project's launch.

At 10:18 a.m., amidst an uplifting atmosphere, the groundbreaking ceremony for the Phase I construction project of Jiangsu Yiling Pharmaceutical Development Co., Ltd. officially commenced.

At the ceremony, Mr. Guan Yi, Chairman of Beijing Pharmatech Science & Technology Development Co., Ltd., took the stage first to deliver a speech. He reviewed in detail the entire process of the Jiangsu Yiling project—from contract signing and preliminary preparations to the ground breaking—and expressed sincere gratitude to the Jinhu County Party Committee, the County Government, and all functional departments for their precise coordination, full-process support, and strong assistance. He noted that the Jiangsu Yiling project is an important part of the group's strategic layout for the full pharmaceutical industry chain, and is of great significance for broadening the group's industrial presence in the Yangtze River Delta and addressing regional industrial gaps. In the future, the group will adhere to the principles of high-standard planning, high-quality construction, and efficient execution, steadily advancing the Phase I project in an orderly manner. The goal is to build a benchmark project for intelligent manufacturing of high-end preparations, driving the group's high-quality development with a quality project and empowering the iterative upgrading of Jinhu's local pharmaceutical industry.

Mr. Xu Jun, General Manager of Jinhu County Hucheng Construction Co., Ltd. and the project's construction lead, also delivered a speech. He stated that being entrusted with the construction of this key Phase I project of Jiangsu Yiling is both an honor and a significant responsibility for his company. In the subsequent construction, the team will strictly adhere to design standards and industry construction norms, uphold the principles of scientific construction, meticulous management, and safety-first, rationally allocate construction resources, optimize construction planning, and rigorously control project safety, construction quality, and schedule. They will go all out to build the project into a safe, reliable, and high-quality exemplary project, ensuring early completion, delivery, and operational commencement.

Amidst thunderous applause and celebratory firecrackers, with all guests present as witnesses, leaders from Jinhu County and other attendees moved to the foundation area, took golden shovels, and broke ground together. Each shovelful of earth laid a solid foundation for development, and each heartfelt commitment set the course for a new journey. The successful start of the Jiangsu Yiling Phase I project fully demonstrates Pharmatech Group's mature full-industry-chain operational capabilities and its strong momentum for in-depth expansion.

Looking ahead, the project will deeply leverage the group's profound technical expertise, industrial resources, and platform advantages in the CRO and MAH fields, continuously revitalizing Jinhu's pharmaceutical industry, promoting regional industrial agglomeration, upgrading, and innovation, and injecting strong momentum into the high-quality development of the Yangtze River Delta biomedical industry.

With fertile ground primed for growth, the future holds great promise. We look forward to the Jiangsu Yiling project rising swiftly on this industrial hotbed, delivering tangible results, and contributing robustly to the advancement of the greater health industry and the wellbeing of the nation.